Anthropic: $200 Million Partnership With Gates Foundation

By Amit Chowdhry • Today at 3:54 PM

Anthropic announced a $200 million partnership with the Gates Foundation to expand the use of AI across global health, life sciences, education, and economic mobility initiatives over the next four years.

The partnership includes grant funding, Claude usage credits, and technical support for programs operating in the U.S. and internationally. The initiative is being led through Anthropic’s Beneficial Deployments team, which focuses on extending AI access in areas where commercial markets alone may not provide sufficient support.

A major focus of the collaboration will center on improving healthcare outcomes in low- and middle-income countries. Anthropic and the Gates Foundation plan to work on programs aimed at accelerating vaccine and therapy development while helping governments use health data for faster and more informed decision-making. The companies will also develop healthcare-focused AI connectors, benchmarks, and evaluation frameworks to better measure how AI systems perform on medical and public health tasks.

The partnership will additionally explore how AI can support frontline healthcare workers through diagnosis, treatment navigation, workforce deployment, supply chain management, and outbreak detection. Anthropic said Claude is already being used by scientists to analyze large datasets, detect research patterns, and screen potential drug and vaccine candidates.

As part of the initiative, the organizations will expand research efforts around high-burden and neglected diseases, including polio, HPV, and preeclampsia. Anthropic said the collaboration aims to help researchers computationally screen vaccine and therapy candidates before pre-clinical development, potentially shortening early-stage research timelines.

Anthropic is also partnering with the Institute for Disease Modeling to improve disease forecasting models related to illnesses such as malaria and tuberculosis. Claude integrations are expected to make those forecasting tools more accessible to researchers and public health practitioners.

In education, the partnership will support the development of AI-powered tools for K-12 students in the U.S., sub-Saharan Africa, and India. The organizations plan to create public resources including benchmarks, datasets, and knowledge graphs designed to improve math tutoring, curriculum development, and college advising systems.

Anthropic said Claude will also support evidence-based tutoring tools and career guidance applications for students transitioning into the workforce. In sub-Saharan Africa and India, the companies are developing literacy and numeracy applications as part of the broader Global AI for Learning Alliance.

The economic mobility portion of the partnership includes work focused on agricultural productivity and workforce development. Anthropic plans to create agriculture-specific enhancements to Claude, along with crop datasets and evaluation benchmarks designed for agricultural applications.

In the U.S., the organizations will also explore tools for portable skills records, AI-powered career guidance, and systems that connect workforce training data with employment outcomes to better evaluate economic mobility programs.

Anthropic said it plans to continue expanding its investments in beneficial AI deployments and intends to publish additional information about the programs and lessons learned as the partnership develops.

KEY QUOTES:

“We’re partnering with the Gates Foundation to commit $200 million in grant funding, Claude usage credits, and technical support for programs in global health, life sciences, education, and economic mobility over the next four years.”

“This commitment is central to Anthropic’s efforts to extend the benefits of AI in areas where markets alone will not.”

Anthropic

“Together, we will explore how AI can make it faster and easier for scientists to screen potential vaccine candidates, including vaccines that protect against diseases like polio, computationally before moving into pre-clinical development.”

“As we scale our partnership over the coming years, and as we ratchet up our work on beneficial deployments more generally, we expect to learn much more about how Claude can make a difference.”

Anthropic